These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 34818971)

  • 1. MiR-191-5p alleviates microglial cell injury by targeting Map3k12 (mitogen-activated protein kinase kinase kinase 12) to inhibit the MAPK (mitogen-activated protein kinase) signaling pathway in Alzheimer's disease.
    Wan W; Liu G; Li X; Liu Y; Wang Y; Pan H; Hu J
    Bioengineered; 2021 Dec; 12(2):12678-12690. PubMed ID: 34818971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Src kinase activity attenuates amyloid associated microgliosis in a murine model of Alzheimer's disease.
    Dhawan G; Combs CK
    J Neuroinflammation; 2012 Jul; 9():117. PubMed ID: 22673542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-335-5p Inhibits β-Amyloid (Aβ) Accumulation to Attenuate Cognitive Deficits Through Targeting c-jun-N-terminal Kinase 3 in Alzheimer's Disease.
    Wang D; Fei Z; Luo S; Wang H
    Curr Neurovasc Res; 2020; 17(1):93-101. PubMed ID: 32003672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-25 aggravates Aβ1-42-induced hippocampal neuron injury in Alzheimer's disease by downregulating KLF2 via the Nrf2 signaling pathway in a mouse model.
    Duan Q; Si E
    J Cell Biochem; 2019 Sep; 120(9):15891-15905. PubMed ID: 31144355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of miR-181c-5p in Alzheimer's disease weakens the response of microglia to Aβ phagocytosis.
    Li R; Yao S; Wei F; Chen M; Zhong Y; Zou C; Chen L; Wei L; Yang C; Zhang X; Liu Y
    Sci Rep; 2024 May; 14(1):11487. PubMed ID: 38769091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-20b-5p aggravates neuronal apoptosis induced by β-Amyloid via down-regulation of Ras homolog family member C in Alzheimer's disease.
    Tian Z; Dong Q; Wu T; Guo J
    Neurosci Lett; 2021 Jan; 742():135542. PubMed ID: 33278507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zerumbone ameliorates behavioral impairments and neuropathology in transgenic APP/PS1 mice by suppressing MAPK signaling.
    Li L; Wu XH; Zhao XJ; Xu L; Pan CL; Zhang ZY
    J Neuroinflammation; 2020 Feb; 17(1):61. PubMed ID: 32066466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-216a-5p ameliorates learning-memory deficits and neuroinflammatory response of Alzheimer's disease mice via regulation of HMGB1/NF-κB signaling.
    Shao P
    Brain Res; 2021 Sep; 1766():147511. PubMed ID: 33957091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-107-5p ameliorates neurological damage, oxidative stress, and immune responses in mice with Alzheimer's disease by suppressing the Toll-like receptor 4 (TLR4)/nuclear factor-kappaB(NF-κB) pathway.
    Hu GJ; Jiang XY; Du SY; Zhang K; Chen Z
    Kaohsiung J Med Sci; 2024 Feb; 40(2):119-130. PubMed ID: 38305705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing of long noncoding RNA X-inactive specific transcript alleviates Aβ1-42-induced microglia-mediated neurotoxicity by shifting microglial M1/M2 polarization.
    Zhao KP; Wang XY; Shao MQ; He CY; Yuan FQ
    Int J Immunopathol Pharmacol; 2023; 37():3946320231184988. PubMed ID: 37400958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-142 downregulation alleviates the impairment of spatial learning and memory, reduces the level of apoptosis, and upregulates the expression of pCaMKII and BAI3 in the hippocampus of APP/PS1 transgenic mice.
    Fu CH; Han XY; Tong L; Nie PY; Hu YD; Ji LL
    Behav Brain Res; 2021 Sep; 414():113485. PubMed ID: 34302879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiRNA let-7d-5p Alleviates Inflammatory Responses by Targeting Map3k1 and Inactivating ERK/p38 MAPK Signaling in Microglia.
    Fang F; Chen C
    Crit Rev Immunol; 2024; 44(6):13-25. PubMed ID: 38848290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD45 opposes beta-amyloid peptide-induced microglial activation via inhibition of p44/42 mitogen-activated protein kinase.
    Tan J; Town T; Mori T; Wu Y; Saxe M; Crawford F; Mullan M
    J Neurosci; 2000 Oct; 20(20):7587-94. PubMed ID: 11027218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetrahydrocurcumin ameliorates Alzheimer's pathological phenotypes by inhibition of microglial cell cycle arrest and apoptosis via Ras/ERK signaling.
    Xiao Y; Dai Y; Li L; Geng F; Xu Y; Wang J; Wang S; Zhao J
    Biomed Pharmacother; 2021 Jul; 139():111651. PubMed ID: 34243602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MAPK-activated protein kinase 2 deficiency in microglia inhibits pro-inflammatory mediator release and resultant neurotoxicity. Relevance to neuroinflammation in a transgenic mouse model of Alzheimer disease.
    Culbert AA; Skaper SD; Howlett DR; Evans NA; Facci L; Soden PE; Seymour ZM; Guillot F; Gaestel M; Richardson JC
    J Biol Chem; 2006 Aug; 281(33):23658-67. PubMed ID: 16774924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CircAXL Knockdown Alleviates Aβ
    Meng S; Wang B; Li W
    Neurochem Res; 2022 Jun; 47(6):1707-1720. PubMed ID: 35229272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-30a-5p induces Aβ production via inhibiting the nonamyloidogenic pathway in Alzheimer's disease.
    Sun T; Zhao K; Liu M; Cai Z; Zeng L; Zhang J; Li Z; Liu R
    Pharmacol Res; 2022 Apr; 178():106153. PubMed ID: 35257899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The p38 mitogen-activated protein kinase signaling pathway is involved in regulating low-density lipoprotein receptor-related protein 1-mediated β-amyloid protein internalization in mouse brain.
    Ma KG; Lv J; Hu XD; Shi LL; Chang KW; Chen XL; Qian YH; Yang WN; Qu QM
    Int J Biochem Cell Biol; 2016 Jul; 76():75-86. PubMed ID: 27163530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of microRNA-330 on amyloid β-protein production, oxidative stress, and mitochondrial dysfunction in Alzheimer's disease by targeting VAV1 via the MAPK signaling pathway.
    Zhou Y; Wang ZF; Li W; Hong H; Chen J; Tian Y; Liu ZY
    J Cell Biochem; 2018 Jul; 119(7):5437-5448. PubMed ID: 29369410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-146a switches microglial phenotypes to resist the pathological processes and cognitive degradation of Alzheimer's disease.
    Liang C; Zou T; Zhang M; Fan W; Zhang T; Jiang Y; Cai Y; Chen F; Chen X; Sun Y; Zhao B; Wang Y; Cui L
    Theranostics; 2021; 11(9):4103-4121. PubMed ID: 33754051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.